Skip to main navigation Skip to search Skip to main content

A catalog of genetic loci associated with kidney function from analyses of a million individuals

  • LifeLines Cohort Study
  • , V. A. Million Veteran Program
  • University of Freiburg
  • University of Utah
  • Glaxo Smith Kline
  • Washington University in St. Louis
  • University of Regensburg
  • Johns Hopkins University
  • Merck Sharp and Dohme
  • University of Leipzig
  • LIFE - Leipzig Research Center for Civilization Diseases
  • Vanderbilt University
  • National University Health System
  • University of Iceland
  • Loyola University Chicago
  • Institute of Genetics and Biophysics Adriano Buzzati-Traverso - CNR
  • University of Edinburgh
  • Institute for Maternal and Child Health
  • IRCCS Ospedale Infantile Burlo Garofolo - Trieste
  • University of Greifswald
  • University of Groningen
  • Erasmus University Medical Center
  • California State University Los Angeles
  • Laboratory for Statistical Analysis
  • RIKEN Center for Integrative Medical Science
  • Graduate School of Medical Sciences
  • University of London
  • Steno Diabetes Center
  • Lund University
  • Karolinska Institutet
  • School of Health and Social Studies
  • Dalarna University
  • University of Washington, Seattle
  • Kidney Research Institute
  • University Hospital and Medical Faculty
  • University of Lausanne
  • Swiss Institute of Bioinformatics
  • University of Cape Town
  • Institute of Molecular Genetics
  • National Research Council, Institute of Biomedical Technologies
  • University of Michigan
  • Baylor College of Medicine
  • Université Lille-Nord de France
  • Charles Bronfman Institute for Personalized Medicine
  • Mount Sinai School of Medicine
  • Digital Health Center
  • Universität Potsdam
  • German Cancer Research Center
  • Ruprecht-Karls Universität Heidelberg
  • University of Trieste

Abstract

Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic complications. Through trans-ancestry meta-analysis of genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replication (n = 1,046,070), we identified 264 associated loci (166 new). Of these, 147 were likely to be relevant for kidney function on the basis of associations with the alternative kidney function marker blood urea nitrogen (n = 416,178). Pathway and enrichment analyses, including mouse models with renal phenotypes, support the kidney as the main target organ. A genetic risk score for lower eGFR was associated with clinically diagnosed CKD in 452,264 independent individuals. Colocalization analyses of associations with eGFR among 783,978 European-ancestry individuals and gene expression across 46 human tissues, including tubulo-interstitial and glomerular kidney compartments, identified 17 genes differentially expressed in kidney. Fine-mapping highlighted missense driver variants in 11 genes and kidney-specific regulatory variants. These results provide a comprehensive priority list of molecular targets for translational research.

Original languageEnglish
JournalNature Genetics
Volume51
Issue number6
Pages (from-to)957-972
Number of pages16
ISSN1061-4036
DOIs
Publication statusPublished - 01.06.2019

Funding

is supported by a consulting contract between Data Tecnica International and the National Institute on Aging (NIA), National Institutes of Health (NIH) and consults for Illumina, the Michael J. Fox Foundation and University of California Healthcare. O.H.F. works in ErasmusAGE, a center for aging research across the life course funded by Nestlé Nutrition (Nestec); Metagenics; and AXA. K.B.S., L.Y.-A., D.M.W. and M.A.L. are full-time employees of GlaxoSmithKline. M.L.O’D. received grant support from GlaxoSmithKline, MSD, Eisai, AstraZeneca, MedCo and Janssen. H.W. received grants and non-financial support from GlaxoSmithKline, during the conduct of the study; grants from Sanofi-Aventis, Eli Lilly, the National Institute of Health, Omthera Pharmaceuticals, Pfizer New Zealand, Elsai Inc. and Dalcor Pharma UK; honoraria and non-financial support from AstraZeneca; and is on advisory boards for Sirtex and Acetilion and received personal fees from CSL Behring and American Regent outside the scope of the submitted work. L. Wallentin received institutional grants from GlaxoSmithKline, AstraZeneca, BMS, Boehringer-Ingelheim, Pfizer, MSD and Roche Diagnostics. D.F.R. and A.I.P. are employees of MSD. M. Scholz received consultancy of and grant support from Merck Serono not related to this project. B.M.P. serves on the DSMB of a clinical trial funded by the manufacturer (Zoll LifeCor) and on the steering committee of the Yale Open Data Access Project funded by Johnson & Johnson. J. Danesh is a member of the Novartis Cardiovascular and Metabolic Advisory Board and received grant support from Novartis. A.S.B. received grants from MSD, Pfizer, Novartis, Biogen and Bioverativ and personal fees from Novartis. V.S. has participated in a conference trip sponsored by Novo Nordisk and received a honorarium from the same source for participating in an advisory board meeting. A. Köttgen received grant support from Gruenenthal. All other authors declare no conflicts of interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A catalog of genetic loci associated with kidney function from analyses of a million individuals'. Together they form a unique fingerprint.

Cite this